  See all
 |
Articles: Clinical Pharmacology |
Prior Articles
Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the age of remission?
Expert Opinion on Investigational Drugs, 10/13/09
Investigation of occurrence of osteonecrosis of the femoral head after increasing corticosteroids in patients with recurring systemic lupus erythematosus
Rheumatology International, 10/12/09 Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cells
Arthritis Research & Therapy, 10/12/09
Free full text
Effective anti-tnf-î± therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis
Journal of Rheumatology, 10/09/09 Ultrasonographic monitoring of response to therapy in polymyalgia rheumatica
Annals of Rheumatic Diseases, 10/09/09 Effect of nonsteroidal anti-inflammatory drug plasters for knee osteoarthritis in Japanese: a randomized controlled trial
Modern Rheumatology, 10/09/09 Oral or transdermal opioids for osteoarthritis of the knee or hip
Cochrane Reviews, 10/09/09
Revew Article
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
Cochrane Reviews, 10/09/09
Revew Article
Rituximab Therapy Produced Rapid and Sustained Clinical Improvement in a Patient With Systemic Onset Juvenile Idiopathic Arthritis Refractory to TNF Alpha Antagonists
Journal of Clinical Rheumatology (JCR), 10/09/09 New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome
Current Rheumatology Reports, 10/09/09 Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics
Modern Rheumatology, 10/08/09 Treatment of adult inflammatory myositis with rituximab: An emerging therapy for refractory patients
Journal of Clinical Rheumatology (JCR), 10/08/09 Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients
Rheumatology, 10/08/09 The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: A systematic comparison of 3- and 6-month response rates in trials of biologic agents.
Annals of Rheumatic Diseases, 10/08/09
Exclusive Author Commentary Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica
Rheumatology, 10/08/09 Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/08/09 The modern management of gout
Rheumatology, 10/08/09 Employer Model of Workplace Impacts of Anti-TNF Therapy for Rheumatoid Arthritis
Journal of Occupational and Environmental Medicine, 10/08/09 TNF-alpha gene polymorphisms in Iranian Azeri Turkish patients with Behcet’s Disease
Rheumatology International, 10/08/09 Raloxifene: its ossification-promoting effect on female mesenchymal stem cells
Journal of Orthopaedic Science, 10/08/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology
more...
|
250 Available Pages
|
|
